Kris Siemionow
Chief Executive Officer bei Holo Surgical, Inc.
Profil
Kris Siemionow is the founder of Biofund Capital Management LLC, founded in 2015, and Holo Surgical, Inc., founded in 2015, where he holds the title of Chief Executive Officer.
He is also the founder of Dystrogen Therapeutics Corp., founded in 2017, where he currently holds the title of Chief Executive Officer.
Dr. Siemionow's former job was as Chief Medical Officer at Surgalign Holdings, Inc.
Aktive Positionen von Kris Siemionow
| Unternehmen | Position | Beginn |
|---|---|---|
Holo Surgical, Inc.
 Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL. | Chief Executive Officer | 01.01.2015 |
Dystrogen Therapeutics Corp.
 Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Chief Executive Officer | 01.01.2017 |
Ehemalige bekannte Positionen von Kris Siemionow
| Unternehmen | Position | Ende |
|---|---|---|
| Biofund Capital Management LLC | Founder | - |
| SURGALIGN HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Surgalign Holdings, Inc.
 Surgalign Holdings, Inc. Medical SpecialtiesHealth Technology Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL. | Health Technology |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Technology Services |
Holo Surgical, Inc.
Holo Surgical, Inc. Medical SpecialtiesHealth Technology Holo Surgical, Inc. engages in operation of a digital surgery company. Its technology focuses on improving patient outcomes by bringing Augmented Reality and Artificial Intelligence to the operating room. The company was founded by Cristian Luciano and Kris Siemionow in 2015 and is headquartered in Chicago, IL. | Health Technology |
| Biofund Capital Management LLC |
